CareRx Ev To Sales from 2010 to 2025

CRRX Stock  CAD 2.65  0.02  0.75%   
CareRx Corp EV To Sales yearly trend continues to be very stable with very little volatility. EV To Sales is likely to grow to 1.07 this year. EV To Sales is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. View All Fundamentals
 
EV To Sales  
First Reported
2010-12-31
Previous Quarter
0.57
Current Value
1.07
Quarterly Volatility
0.3636205
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CareRx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareRx Corp's main balance sheet or income statement drivers, such as Interest Expense of 10.5 M, Selling General Administrative of 28.8 M or Other Operating Expenses of 439 M, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.0 or PTB Ratio of 1.24. CareRx financial statements analysis is a perfect complement when working with CareRx Corp Valuation or Volatility modules.
  
This module can also supplement various CareRx Corp Technical models . Check out the analysis of CareRx Corp Correlation against competitors.

Other Information on Investing in CareRx Stock

CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.